feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
Annexin Q2’19: Kort kommentar
Research Note
2019-08-22
09:03
Annexin Pharmaceuticals publicerade imorse sin delårsrapport över det andra kvartalet 2019 vilket vi nedan ger en kort kommentar till.
AH
Anders Hedlund
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans